Ellevest Inc’s Abeona Therapeutics ABEO Stock Holding History

Ellevest Inc’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-33	Closed	-$1K	–	1367
2021 Q2	$1K	Buy	33 +2	+6%	+$82	﹤0.01%	1108
2021 Q1	$1K	Hold	31	–	–	﹤0.01%	1118
2020 Q4	$1K	Buy	+31	New	+$1.06K	﹤0.01%	1017
2020 Q3	–	Sell	-3	Closed	–	–	1113
2020 Q2	$0	Sell	3 -10	-77%	-$691	﹤0.01%	1100
2020 Q1	$1K	Buy	+13	New	+$868	﹤0.01%	826

Other funds holding ABEO

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Ellevest Inc's ABEO Position: Q3 2021 in Review

Ellevest Inc sold out of Abeona Therapeutics (ABEO) in Q3 2021, closing a stake of 33 shares — an estimated $1K sold.

Ellevest Inc first reported a position in ABEO in Q1 2020 and held it in 5 quarters. The position peaked at $1K in Q2 2021. 58 funds tracked by Wall St. Rank hold ABEO as of Q3 2021.

Ellevest Inc reported no remaining Abeona Therapeutics position as of Q3 2021 after selling out during the quarter.
Ellevest Inc sold 33 Abeona Therapeutics shares in Q3 2021, an estimated $1K.
Ellevest Inc first reported a position in Abeona Therapeutics in Q1 2020 and held it in 5 quarters.
Ellevest Inc's Abeona Therapeutics position peaked at $1K in Q2 2021.
58 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2021.

Based on Ellevest Inc's 13F filing for Q3 2021, filed 19 Oct 2021.